Te‐yuan Chyou

599 total citations
29 papers, 398 citations indexed

About

Te‐yuan Chyou is a scholar working on Toxicology, Geriatrics and Gerontology and Molecular Biology. According to data from OpenAlex, Te‐yuan Chyou has authored 29 papers receiving a total of 398 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Toxicology, 6 papers in Geriatrics and Gerontology and 5 papers in Molecular Biology. Recurrent topics in Te‐yuan Chyou's work include Pharmacovigilance and Adverse Drug Reactions (8 papers), Pharmaceutical Practices and Patient Outcomes (6 papers) and CRISPR and Genetic Engineering (3 papers). Te‐yuan Chyou is often cited by papers focused on Pharmacovigilance and Adverse Drug Reactions (8 papers), Pharmaceutical Practices and Patient Outcomes (6 papers) and CRISPR and Genetic Engineering (3 papers). Te‐yuan Chyou collaborates with scholars based in New Zealand, United Kingdom and Australia. Te‐yuan Chyou's co-authors include Prasad S. Nishtala, Peter C. Fineran, Mohammed S. Salahudeen, Chris M. Brown, Michael G. Paulin, Anne Chevallereau, Clare Rollie, Patries M. Herst, Jing Yan and Edze R. Westra and has published in prestigious journals such as Nature, Nucleic Acids Research and PLoS ONE.

In The Last Decade

Te‐yuan Chyou

28 papers receiving 387 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Te‐yuan Chyou New Zealand 11 117 53 53 52 44 29 398
James B. Williams United States 15 131 1.1× 31 0.6× 13 0.2× 168 3.2× 180 4.1× 33 850
Karine Moreau France 14 57 0.5× 28 0.5× 14 0.3× 123 2.4× 16 0.4× 42 787
Zhitao Li China 13 136 1.2× 58 1.1× 11 0.2× 62 1.2× 73 1.7× 47 585
Arne Søraas Norway 14 111 0.9× 14 0.3× 17 0.3× 177 3.4× 6 0.1× 31 704
Masaaki Kojima Japan 9 35 0.3× 7 0.1× 16 0.3× 93 1.8× 37 0.8× 28 472
Luis Ortiz‐Reyes United States 14 148 1.3× 5 0.1× 15 0.3× 51 1.0× 28 0.6× 28 840
Sylvia Krämer Germany 10 53 0.5× 41 0.8× 33 0.6× 6 0.1× 322 7.3× 14 1.2k
Zuriati Ibrahim Malaysia 13 167 1.4× 3 0.1× 63 1.2× 29 0.6× 42 1.0× 48 551
Anton De Spiegeleer Belgium 10 132 1.1× 6 0.1× 61 1.2× 36 0.7× 19 0.4× 26 599
Jihye Kim South Korea 13 55 0.5× 11 0.2× 8 0.2× 84 1.6× 14 0.3× 48 475

Countries citing papers authored by Te‐yuan Chyou

Since Specialization
Citations

This map shows the geographic impact of Te‐yuan Chyou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Te‐yuan Chyou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Te‐yuan Chyou more than expected).

Fields of papers citing papers by Te‐yuan Chyou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Te‐yuan Chyou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Te‐yuan Chyou. The network helps show where Te‐yuan Chyou may publish in the future.

Co-authorship network of co-authors of Te‐yuan Chyou

This figure shows the co-authorship network connecting the top 25 collaborators of Te‐yuan Chyou. A scholar is included among the top collaborators of Te‐yuan Chyou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Te‐yuan Chyou. Te‐yuan Chyou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chyou, Te‐yuan, et al.. (2024). Diversification of the Rho transcription termination factor in bacteria. Nucleic Acids Research. 52(15). 8979–8997. 3 indexed citations
2.
Chyou, Te‐yuan, et al.. (2024). Antibiotic-Associated Acute Kidney Injury Among Older Adults: A Case-Crossover Study. Clinical Drug Investigation. 44(2). 131–139. 2 indexed citations
3.
Chyou, Te‐yuan, et al.. (2023). Acute renal failure and cardiac arrhythmias associated with remdesivir use in patients with COVID-19 infections: Analysis using the US FDA adverse event reporting system. International Journal of Risk & Safety in Medicine. 34(2). 87–99. 2 indexed citations
4.
Chyou, Te‐yuan, et al.. (2022). Analysis of the nervous system and gastrointestinal adverse events associated with solifenacin in older adults using the US FDA adverse event reporting system. International Journal of Risk & Safety in Medicine. 34(1). 63–73. 1 indexed citations
5.
Nishtala, Prasad S. & Te‐yuan Chyou. (2022). An Updated Analysis of Psychotropic Medicine Utilisation in Older People in New Zealand from 2005 to 2019. Drugs & Aging. 39(8). 657–669. 1 indexed citations
6.
Nishtala, Prasad S. & Te‐yuan Chyou. (2022). Risk of delirium associated with antimuscarinics in older adults: A case‐time‐control study. Pharmacoepidemiology and Drug Safety. 31(8). 883–891. 7 indexed citations
7.
8.
Chyou, Te‐yuan, et al.. (2020). Safety of fluoxetine use in children and adolescents: a disproportionality analysis of the Food and Drug Administration Adverse Event Reporting System (FAERS) database. European Journal of Clinical Pharmacology. 76(12). 1775–1776. 2 indexed citations
9.
Rollie, Clare, Anne Chevallereau, Bridget N. J. Watson, et al.. (2020). Targeting of temperate phages drives loss of type I CRISPR–Cas systems. Nature. 578(7793). 149–153. 58 indexed citations
10.
Chyou, Te‐yuan, et al.. (2020). Comparative risk of Parkinsonism associated with olanzapine, risperidone and quetiapine in older adults‐a propensity score matched cohort study. Pharmacoepidemiology and Drug Safety. 29(6). 692–700. 6 indexed citations
11.
Nishtala, Prasad S., Hamish A. Jamieson, Carl Hanger, Te‐yuan Chyou, & Sarah N. Hilmer. (2019). Examining the Risks of Major Bleeding Events in Older People Using Antithrombotics. Cardiovascular Drugs and Therapy. 33(3). 323–329. 6 indexed citations
12.
Nishtala, Prasad S., Te‐yuan Chyou, Fabian Held, David G. Le Couteur, & Danijela Gnjidic. (2018). Association rules method and big data: Evaluating frequent medication combinations associated with fractures in older adults. Pharmacoepidemiology and Drug Safety. 27(10). 1123–1130. 10 indexed citations
13.
Nishtala, Prasad S., et al.. (2017). An overview of pharmacoepidemiology in New Zealand: medical databases, registries and research achievements.. PubMed. 130(1449). 52–61. 9 indexed citations
14.
Chyou, Te‐yuan & Friedlieb Lorenz. (2017). Couch modelling for volumetric modulated arc therapy (VMAT). Australasian Physical & Engineering Sciences in Medicine. 40(2). 471–480.
15.
Nishtala, Prasad S. & Te‐yuan Chyou. (2017). Zopiclone Use and Risk of Fractures in Older People: Population-Based Study. Journal of the American Medical Directors Association. 18(4). 368.e1–368.e8. 20 indexed citations
16.
Nishtala, Prasad S. & Te‐yuan Chyou. (2016). Exploring New Zealand prescription data using sequence symmetry analyses for predicting adverse drug reactions. Journal of Clinical Pharmacy and Therapeutics. 42(2). 189–194. 13 indexed citations
17.
Salahudeen, Mohammed S., Te‐yuan Chyou, & Prasad S. Nishtala. (2016). Serum Anticholinergic Activity and Cognitive and Functional Adverse Outcomes in Older People: A Systematic Review and Meta-Analysis of the Literature. PLoS ONE. 11(3). e0151084–e0151084. 43 indexed citations
18.
Nishtala, Prasad S. & Te‐yuan Chyou. (2016). Real-world risk of diabetes with antipsychotic use in older New Zealanders: a case-crossover study. European Journal of Clinical Pharmacology. 73(2). 233–239. 6 indexed citations
19.
Chyou, Te‐yuan, et al.. (2011). An upper-body can improve the stability and efficiency of passive dynamic walking. Journal of Theoretical Biology. 285(1). 126–135. 33 indexed citations
20.
Chyou, Te‐yuan, et al.. (2007). Quaternary structure of Artemia haemoglobin II: analysis of T and C polymer alignment and interpolymer interface. BMC Structural Biology. 7(1). 26–26. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James B. Williams Breakdown of academic impact, for papers by Karine Moreau Breakdown of academic impact, for papers by Zhitao Li Breakdown of academic impact, for papers by Arne Søraas Breakdown of academic impact, for papers by Masaaki Kojima Breakdown of academic impact, for papers by Luis Ortiz‐Reyes Breakdown of academic impact, for papers by Sylvia Krämer Breakdown of academic impact, for papers by Zuriati Ibrahim Breakdown of academic impact, for papers by Anton De Spiegeleer Breakdown of academic impact, for papers by Jihye Kim
Rankless by CCL
2026